Mesoblast Limited vs Uranium Energy Corp — how do they compare? Mesoblast Limited trades at $16.96 (market cap $2.21B), while Uranium Energy Corp trades at $11.72 (market cap $5.67B). The key difference: Uranium Energy Corp is far larger — about 2.6× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, Uranium Energy Corp nearer its low. Which is the better fit depends on your goals.
| MESO | UEC | |
|---|---|---|
Market Cap | $2.21B | $5.67B |
Sector | Technology | Energy |
52-Week High | $20.96 | $20.14 |
52-Week Low | $12.88 | $9.04 |
Enterprise Value | $2.21B | $5.18B |
Trailing returns across standard periods
Latest headlines on both assets
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Uranium Energy Corp is a leading American uranium mining and exploration company, currently holding the largest resource base and licensed production capacity in the United States. Utilizing low-cost, environmentally friendly In-Situ Recovery (ISR) mining, UEC is a central player in the domestic nuclear fuel supply chain, transitioning from a resource holder to an active producer and refiner to meet the accelerating demand for carbon-free energy.
Read more on UEC →